Yseop reports its regulatory-grade AI supports medical writers across more than 300 clinical trials.
Pharma sponsors need to produce complex documents such as CSRs across the CTD structure faster. Yseop's regulatory document automation is used by leading pharma companies and moving from experiments to large-scale adoption. The page claims 50% productivity gains in medical writing and submissions accelerated by several weeks.
Yseop is a French generative AI and natural language generation vendor, used by large pharma to draft clinical study reports, patient narratives and regulatory documents
This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.
Published by Yseop on its own site — read the original case study on yseop.com ↗
Note: Press feature with aggregate claims; customers not named.
Related use cases
- 01Eli Lilly automated clinical patient narrative drafting with Yseop's natural language generation.
- 02Sanofi automated sections of its clinical study reports with Yseop natural language generation.
- 03Yseop built a generative AI regulatory document tool on Amazon Bedrock and Claude 3.5.
- 04How (And Why) AdeptID Achieved EU AI Act Compliance for Talent Matching
- 05Establishing Lifecycle AI Risk Management for Defense Operations
- 06Unifying AI Governance Across Global Operations at Scale